» Articles » PMID: 12531334

Induction of Immune Responses by DNA Vaccines in Large Animals

Overview
Journal Vaccine
Date 2003 Jan 18
PMID 12531334
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

It is generally recognized that DNA vaccines are often less effective in large animals than in mice. One possible reason for this reduced effectiveness may be transfection deficiency and the low level of expression elicited by plasmid vectors in large animals. In our attempt to enhance transfection efficiency and, thereby, enhance immune responses, we employed a variety of methods inducing gene gun delivery or suppositories as delivery vehicles to mucosal surfaces, as well as electroporation for systemic immunization. To test these different systems, we used two different antigens-a membrane antigen from bovine herpesvirus glycoprotein (BHV-1) gD and a particulate antigen from hepatitis virus B. Gene gun and suppository delivery of BHV-1 gD to the vagina resulted in the induction of mucosal immunity not only in the vagina, but also at other mucosal surfaces. These data support the contention of a common mucosal immune system. In the case of electroporation, we were able to develop significant enhancement of gene expression following electroporation with surface electrodes (non-invasive electroporation) as well as invasive electroporation using single or six-needle electrodes. Various delivery systems such as bioject or needle delivery also influenced the immune response in both the presence and absence of electroporation. These studies also demonstrated that co-administration of plasmids coding for two different antigens (BHV-1 gD and hepatitis B surface antigen (HbsAg)) did not result in significant interference between the plasmids. These studies suggest that various combinations of delivery systems can enhance immunity to DNA-based vaccines and make them practical for administration of these vaccines in large animals.

Citing Articles

A comprehensive investigation of Glycoprotein-based nucleic acid vaccines for Hantaan Virus.

Zhang J, Zhang J, Wang Y, Sun Y, Wang Y, Wang Y NPJ Vaccines. 2024; 9(1):196.

PMID: 39443512 PMC: 11500389. DOI: 10.1038/s41541-024-00991-0.


Development of a dual vaccine against East Coast fever and lumpy skin disease.

Whittle L, Chapman R, Douglass N, Jaffer M, Margolin E, Rybicki E Front Immunol. 2023; 14:1143034.

PMID: 37063887 PMC: 10098110. DOI: 10.3389/fimmu.2023.1143034.


Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review.

Mirmosayyeb O, Ghaffary E, Vaheb S, Pourkazemi R, Shaygannejad V Rev Neurol (Paris). 2023; 179(4):265-281.

PMID: 36658048 PMC: 9844421. DOI: 10.1016/j.neurol.2022.11.004.


DNA vaccines targeting amyloid-β oligomer ameliorate cognitive deficits of aged APP/PS1/tau triple-transgenic mouse models of Alzheimer's disease.

Sha S, Xing X, Wang T, Li Y, Zhang R, Shen X Neural Regen Res. 2022; 17(10):2305-2310.

PMID: 35259854 PMC: 9083157. DOI: 10.4103/1673-5374.337054.


Characterization of a Novel Chimeric p67 Antigen Which Incorporates into Virus-like Particles and Is Highly Immunogenic in Mice.

Whittle L, Chapman R, van Diepen M, Rybicki E, Williamson A Vaccines (Basel). 2022; 10(2).

PMID: 35214669 PMC: 8880696. DOI: 10.3390/vaccines10020210.